LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) today released the following statement following the death Sunday of Francis P. (Frank) Tally, the company’s Chief Scientific Officer. Dr. Tally’s death was announced by the Tally family earlier today.
